Clinical knowledge deficits to slow biotech development, warns Europital
![](/46/pdcnewsitem/11/07/46/HLN00CPO-ClinicalKnowledge990x525.jpg)
The CRO predicts investment communities will come to the rescue of small and medium companies looking to advance their candidates
A clinical knowledge deficit among smaller biotechs could slow drug trials in 2021, the newly formed Scientific Advisory Board (SAB) of contract research organisation, Europital, has warned.
Chief Medical Officer of Europital, Dr Mohamed El Malt, said that during the next few years, small and medium pharma and biotech companies will find accessing appropriate and high-quality knowledge to advance candidates challenging.
Because the drug discovery pipeline is increasingly made up of smaller and more nimble innovators with limited clinical experience in-house, the "low-hanging fruit" has already been developed, leaving the more complex molecules and biologics.
Europital predicts that investment communities — backing many early-stage development programmes — will look holistically at biotechs and their partners to ensure that deep therapeutic expertise is available.
This forensic approach will ensure expeditated development timelines and will de-risk projects, especially as the business and investment model is to prove safety and efficacy for their drug candidates in Phase I and II clinical trials before seeking a sale or further rounds.
“It’s no secret that unlike the larger pharma companies, which can pull in the best resources from the largest CROs, smaller companies must increasingly compete to ensure they can access the best clinical knowledge, as this can be the difference between delays due to poor trial management and planning, and even, a project’s potential success or failure,” added Dr El Malt.
Europital created the SAB, which comprises a group of clinical key opinion leaders and specialised industry experts, to address many of the more complex targets and biologies that now proliferate in the drug discovery pipeline.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance